Roberta Cillari

Dr. Roberta Cillari

University of Palermo, Palermo, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Nicolò MauroNicolò Mauro
Nicolò Mauro
MUMara Utzeri
Mara Utzeri
RCRoberta Cillari
Roberta Cillari
CSCinzia Scialabba
Cinzia Scialabba
Gaetano GiammonaGaetano Giammona
Gaetano Giammona
Gennara CavallaroGennara Cavallaro
Gennara Cavallaro
An amphiphilic inulin-thiocholesterol conjugate (INU-Cys-TC) was strategically designed as a biodegradable core-shell nanocarrier of 7-ethyl-10-hydroxy-camptothecin (SN38) to enhance its solubility and stability in aqueous media, thus exploiting its brilliant anticancer effect. INU-Cys-TC was designed to have the hydrophilic inulin backbone (external shell) partially functionalized with hydrophobic thiocholesterol moieties (internal core) through a biodegradable disulfide bond due to cysteamine bridges. Thiocholesterol moieties impair redox-sensitive self-assembling abilities, yielding to nano-sized micelles in aqueous media capable of efficiently encapsulating a high amount of SN38 (DL = 8.1%). Micelles (INU-Cys-TC@SN38) were widely characterized, demonstrating an effective and stable delivery strategy to overcome the poor water-solubility of SN38. SN38-loaded micelles showed a gradual and prolonged release of SN38 over time, and a cell- and time-dependent cytotoxicity. In particular, we show that micelles efficiently deliver SN38 inside cell nuclei, and, compared to normal cell lines, they can also enter cancer cells by endo-lysosomes, where a complete degradation can occur releasing the drug payload. Overall, the proposed micelles appear potentially effective as nanomedicines for precision cancer therapies of colorectal and breast cancer, thus improving the SN38 therapeutic index and extending its use in a huge plethora of cancers.

28 February 2025 in Journal of Controlled Release
Verified
Journal Article
Open access
RCRoberta Cillari
Roberta Cillari
RARita C. Acúrcio
Rita C. Acúrcio
ABAndreia Barateiro
Andreia Barateiro
HFHelena Florindo
Helena Florindo
Nicolò MauroNicolò Mauro
Nicolò Mauro
Gennara CavallaroGennara Cavallaro
Gennara Cavallaro
Fluorescent ultrasmall nanoparticles (d < 10 nm), such as carbon nanodots (CDs), are promising nanosystems for precision cancer therapy. Their optimal size allows them to diffuse within complex microenvironments, enabling drug delivery, imaging, and monitoring. Additionally, CDs can be engineered to hold inherent nanotoxicity toward cancer cells, overcoming multidrug resistance associated with conventional drugs. Nevertheless, cancer is a multifactorial disease where combinational strategies are most likely to tackle metastatic tumors and efficiently avoid recidivism. Therefore, developing multifunctional CDs that exhibit intrinsic nanotoxicity against cancer cells and drive effective antitumor immune responses is a promising approach to improving patients' response rates. Here, we developed an innovative nanosystem by conjugating N-,S-doped CDs with indoximod (IND) through a simple and cost-effective method. Our CDs-IND not only retained the advantages of bare CDs, including photoluminescence for self-tracking but also significantly controlled breast cancer progression in vivo following CDs-IND intratumoral (IT) and intravenous (IV) administration. Tumor microenvironment (TME) immune profiling revealed that CDs-IND reduced IDO expression and recruited NK, NKT, and T cells. This study underscores the potential of combining the inherent pharmacological properties of CDs with indoximod-mediated immunotherapy, offering a promising strategy for precision breast cancer treatment.

12 September 2025 in Environmental Research
Verified
Journal Article
Open access
IDInês Domimgues
Inês Domimgues
JAJoão Amaral
João Amaral
BVBruna Vieira
Bruna Vieira
AMAna Luísa Machado
Ana Luísa Machado
CSCarla I.M. Santos
Carla I.M. Santos
GGGil Gonçalves
Gil Gonçalves
Carbon dots (CDs) have emerged as promising agents for mitigating metal toxicity and monitoring metal contamination in aquatic environments. This study investigated the dual functionality of CDs as anti-toxicity agents and biosensors for cadmium (Cd2+), nickel (Ni2+), and silver (Ag+) in a zebrafish embryo model. Zebrafish embryos were exposed to various concentrations of CDs (0, 5, and 50 mg L-1) in combination with different metal concentrations. Toxicity was assessed by measuring the lethality, hatching rate, swimming activity, and AChE activity. CDs significantly reduced the lethal toxicity of all tested metals, with LC50 values increasing from 56.0 to 110.0 μM for Cd2+, 0.4-1.6 μM for Ag+, and becoming undeterminable for Ni2+ at the highest CDs concentration. Photophysical characterization revealed that the CDs exhibited metal-specific fluorescence, enabling the development of an optical fingerprint for metal identification. Fluorescence imaging of zebrafish embryos demonstrated the effectiveness of CDs as in vivo tracers of metallic contaminants, highlighting their utility in studying biological processes. These findings highlight the dual functionality of CDs as agents to reduce metal toxicity and as monitoring tools for water quality assessment, making them a versatile solution for addressing metal contamination challenges in aquatic and biological systems. ENVIRONMENTAL IMPLICATIONS: The present study explores the potential of carbon dots as nanotools for water remediation. Carbon dots have a high absorption capacity and can remove several compounds, including metals, from aquatic environments. This is highly relevant because contamination by metallic compounds is an environmental concern and that technology is constantly being sought to minimize the impact of these compounds on aquatic systems. Due to natural fluorescence which can be changed by metallic ions, carbon dots also show potential for monitoring aquatic contamination contributing as a potential tool in risk assessment strategies.

5 February 2025 in Surfaces and Interfaces
Verified
Journal Article
Open access
MMMarina Macchiaiolo
Marina Macchiaiolo
RCRoberta Cillari
Roberta Cillari
MGMichaela V. Gonfiantini
Michaela V. Gonfiantini
ACANTONELLA CACCHIONE
ANTONELLA CACCHIONE
AMAngela Mastronuzzi
Angela Mastronuzzi
Nicolò MauroNicolò Mauro
Nicolò Mauro

4 April 2024 in C
Verified
Journal Article
Open access
PDF file
RCRoberta Cillari
Roberta Cillari
SSSergio Scirè
Sergio Scirè
Gennara CavallaroGennara Cavallaro
Gennara Cavallaro
Nicolò MauroNicolò Mauro
Nicolò Mauro
Utilizing glucose as a targeting agent represents a pioneering approach in selectively directing nanoparticles towards cancer cells, capitalizing on the pronounced glucose uptake observed in tumors attributable to the Warburg effect. In this study, we have successfully adopted this targeting strategy to facilitate the specific uptake of advanced nanotools, comprising carbon nanocrystals incorporating gold seeds (AuCDs). Leveraging the advantageous optical and size-related properties of carbon nanodots in conjunction with gold-mediated X-ray attenuation capabilities, these hybrid nanomaterials have been engineered as contrast agents for a bi-modal imaging modality, exploiting the synergistic benefits of fluorescence imaging and X-ray computed tomography. Notably, for the synthesis of AuCDs, we present, for the first time, the incorporation of gold seeds within the molecular precursors of carbon nanodots during their solvothermal synthesis process, showcasing the efficacy of this synthetic pathway in yielding nanoscale carbon structures incorporating bioeliminable gold ultrasmall nanoparticles (d < 5 nm). Subsequently, we employed an azido-alkyne click chemistry reaction to functionalize the nanoparticle surface with 2-deoxy-D-glucose as a targeting moiety. The demonstrated cancer-targeting proficiency, as assessed via fluorescence imaging, renders the proposed nanosystem highly promising for a spectrum of applications in precision anticancer theranostics, encompassing both diagnostic and therapeutic endeavors.

14 January 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
RCRoberta Cillari
Roberta Cillari
FTFrancesca Terracina
Francesca Terracina
SSSergio Scirè
Sergio Scirè
Nicolò MauroNicolò Mauro
Nicolò Mauro
GCGennara Cavallaro
Gennara Cavallaro